ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1290

$748K Total Retail Price of All Prescriptions

Rank: 96 out of 1290

980 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 980 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 980 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,371 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 713 674 1 1
OMEPRAZOLE 582 509 2 2
LEVOTHYROXINE SODIUM 489 459 3 4
AMLODIPINE BESYLATE 418 377 4 3
LISINOPRIL 410 386 5 5
PRAVASTATIN SODIUM 301 257 6 42
METFORMIN HCL 271 256 7 10
METOPROLOL TARTRATE 267 260 8 7
HYDROCHLOROTHIAZIDE 263 236 9 20
ATENOLOL 247 234 10 18
ALENDRONATE SODIUM 242 229 11 39
ZOLPIDEM TARTRATE 208 180 12 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 194 189 13 92
FUROSEMIDE 185 182 14 9
LOVASTATIN 176 172 15 45
HYDROCODONE-ACETAMINOPHEN 166 135 S3 16 6
LOSARTAN POTASSIUM 164 148 17 19
AZITHROMYCIN 153 145 18 61
ATORVASTATIN CALCIUM 143 125 19 23
FENOFIBRATE 141 134 20 98
CARVEDILOL 140 132 21 12
SERTRALINE HCL 140 115 21 36
ADVAIR DISKUS 134 133 23 37
MELOXICAM 133 123 24 31
TRAMADOL HCL 131 116 25 25
CIPROFLOXACIN HCL 123 107 26 46
CITALOPRAM HBR 122 105 27 29
ALLOPURINOL 111 108 28 60
SYNTHROID 110 103 29 28
WARFARIN SODIUM 109 109 30 22
POTASSIUM CHLORIDE 104 100 31 35
GLIPIZIDE 94 92 32 81
GLYBURIDE 89 85 R 33 87
GABAPENTIN 89 70 33 8
TEMAZEPAM 88 87 35 71
ALPRAZOLAM 87 73 36 47
METOPROLOL SUCCINATE 86 81 37 14
TRAZODONE HCL 84 77 38 44
IBUPROFEN 77 70 39 74
NEXIUM 76 67 40 34
LOSARTAN-HYDROCHLOROTHIAZIDE 74 74 41 106
CRESTOR 72 65 42 17
ENALAPRIL MALEATE 71 71 43 62
PREMARIN 66 60 R 44 164
PREDNISONE 66 65 44 21
ESTRADIOL 65 58 R 46 177
MECLIZINE HCL 64 60 47 159
DIOVAN 62 54 48 53
METHYLPREDNISOLONE 62 57 48 101
GLIMEPIRIDE 61 59 50 57
DIAZEPAM 59 19 51 261
DIGOXIN 59 59 51 51
METRONIDAZOLE 58 49 53 278
TRIAMTERENE-HCTZ 58 58 53 130
GEMFIBROZIL 57 50 55 210
OXYBUTYNIN CHLORIDE 56 55 56 156
METOCLOPRAMIDE HCL 55 35 57 174
DONEPEZIL HCL 54 54 58 13
OXYCODONE-ACETAMINOPHEN 53 52 S2 59 65
LANTUS 53 53 59 67
FLUOXETINE HCL 52 39 61 79
BENAZEPRIL HCL 52 50 61 140
ACTONEL 52 52 61 207
LIPITOR 50 40 64 195
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.